Levothyroxine for mild underactive thyroid in people having heart bypass surgery
Tests levothyroxine in people with subclinical hypothyroidism undergoing coronary artery bypass surgery.
Key facts
- Who runs it
- Seoul National University Bundang Hospital
- Where
- Seongnam-si, South KoreaSee the site
- Trial code
- Registry title
- Thyroid Hormone Replacement After Coronary Artery Bypass Grafting for Patients With Subclinical Hypothyroidism
- Status
- Recruiting
- People taking part
- 338 people, planned
- Started
- 27 Feb 2022
- Expected to end
- 26 Feb 2037
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- levothyroxine
- Record updated
- 2 February 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with subclinical hypothyroidism who are scheduled for coronary artery bypass graft (CABG) heart surgery. Subclinical hypothyroidism means a mildly underactive thyroid.
- Age
- 19 to 90 years
- Sex
- All sexes
- Disease stage
- Subclinical hypothyroidism: normal free T4 level and a TSH level greater than 4 μIU/mL, tested within 31 days before surgery. People must be scheduled for CABG surgery.
- Earlier treatment
- No LT4 (levothyroxine) in the previous 4 weeks. No antithyroid drugs (propylthiouracil, methimazole or carbimazole) in the previous 3 months.
- Biomarker or test result
- Normal free T4 and TSH greater than 4 μIU/mL, tested within 31 days before surgery.
Main reasons for not taking part
- Repeat CABG surgery
- Emergency CABG surgery
- Use of LT4 within the previous 4 weeks
- Use of antithyroid drugs within the previous 3 months
- Severe other illness with life expectancy under 1 year, such as advanced cancer
The registry criteria, word for word
Show all 8 criteriaShow less
Who cannot take part
- Patients who underwent repeat or emergency CABG surgery
- Use of LT4 within the previous 4 weeks
- Use of antithyroid drug use (propylthiouracil, methimazole, or carbimazole) within the previous 3 months
- Severe comorbid conditions with a life expectancy of less than 1 year (e.g. advanced malignancy)
Other criteria
- Eligibility Criteria
- Adults aged 19 to 90 years
- Patients scheduled to undergo coronary artery bypass graft (CABG) surgery
- Subclinical hypothyroidism (SCH), defined as a normal free thyroxine (free T4) level and a thyroid-stimulating hormone (TSH) level greater than 4 μIU/mL, based on testing performed within 31 days prior to surgery
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 19 and 90 years old?
Where in South Korea
- Department of Internal Medicine, Seoul National University Bundang HospitalSeongnam-si, South KoreaContact: KangTaking people
About the trial
What the trial wants to find out
The goal of this clinical trial is to find out whether levothyroxine reduces complications and improves the prognosis of patients with subclinical hypothyroidism (SCH) undergoing coronary artery bypass grafting (CABG).
Read full original descriptionShow less
The main questions this study aims to answer are:
• Does levothyroxine reduce major adverse cardiovascular events (MACE), including cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, and new arrhythmias, in SCH patients undergoing CABG? Researchers will compare patients who take levothyroxine with those who do not.
Participants will:
* Be randomly assigned to either receive levothyroxine or not * Start the medication one day before surgery if assigned to the treatment group. * Have regular follow-up visits to check thyroid function and cardiovascular events for up to five years after surgery.
The 2 groups in the trial
- LT4 groupTreatment being tested
Participants in this group will receive levothyroxine
Treatment: levothyroxine
- Control groupNo study treatment, for comparison
Participants in this group will not receive levothyroxine
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Thyroid Hormone Replacement After Coronary Artery Bypass Grafting for Patients With Subclinical Hypothyroidism
- Plain-language title
- Levothyroxine for mild underactive thyroid in people having heart bypass surgeryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT07380854, who can take part
- Record updated
- 2 February 2026